Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Eosinophilic esophagitis: an update.

D D Ferguson1, A E Foxx-Orenstein

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota 55905, USA.

Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|January 18, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Efficiency of Biofilters at Mitigating Airborne MRSA from a Swine Nursery.

Journal of agricultural safety and health·2015
Same author

Esophageal leukoplakia: a rare cause of white patches in esophagus with malignant potential.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2014
Same author

Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility.

Neurogastroenterology and motility·2014
Same author

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review.

Gut·2008
Same author

A novel partial 5HT3 agonist DDP733 after a standard refluxogenic meal reduces reflux events: a randomized, double-blind, placebo-controlled pharmacodynamic study.

Alimentary pharmacology & therapeutics·2007
Same author

Does co-administration of a non-selective opiate antagonist enhance acceleration of transit by a 5-HT4 agonist in constipation-predominant irritable bowel syndrome? A randomized controlled trial.

Neurogastroenterology and motility·2007
Same journal

Identification of transient hiatal hernia on high-resolution manometry is associated with gastroesophageal reflux disease.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same journal

Screening for Barrett's esophagus and esophageal adenocarcinoma: recent advances and next steps.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same journal

Limited evidence cannot validate routine gastropexy for paraesophageal hernia repair.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same journal

CD39 and PD-L1 co-expression may serve as potential indicators for evaluating the efficacy of neoadjuvant immunotherapy in esophageal squamous cell carcinoma.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same journal

Diagnostic performance of postoperative endoscopy versus water-soluble esophagram in detecting anastomotic leak after esophagectomy.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same journal

Response to the correspondence on 'Limited Evidence Cannot Validate Routine Gastropexy for Paraesophageal Hernia Repair'.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
See all related articles

Eosinophilic esophagitis (EE) is a growing condition causing feeding issues and difficulty swallowing. Treatment with topical corticosteroids is common, but relapses frequently occur, and long-term outcomes remain unclear.

Area of Science:

  • Gastroenterology
  • Immunology
  • Pediatrics

Background:

  • Eosinophilic esophagitis (EE) is an increasingly recognized immune-mediated esophageal disease.
  • It presents with distinct symptoms in children (feeding disorders, vomiting, abdominal pain) and adults (dysphagia, food impaction).
  • Histological confirmation requires over 20 eosinophils per high-powered field in esophageal biopsies.

Purpose of the Study:

  • To summarize the current understanding of eosinophilic esophagitis.
  • To highlight diagnostic criteria and common treatment approaches.
  • To address the frequency of symptomatic relapse and the unknown long-term prognosis.

Main Methods:

  • Review of current medical literature on eosinophilic esophagitis.
  • Analysis of diagnostic criteria based on esophageal histology.

Related Experiment Videos

  • Evaluation of treatment strategies, primarily topical corticosteroids.
  • Assessment of reported relapse rates and long-term outcome data.

    • Main Results:

    • EE diagnosis relies on specific esophageal eosinophil counts (>20/HPF).
    • Topical corticosteroids are the primary treatment for both pediatric and adult EE.
    • Symptomatic relapse after initial treatment is frequent, necessitating repeated interventions.
    • Long-term prognosis and disease progression data are currently limited.

    Conclusions:

    • Eosinophilic esophagitis is a prevalent condition requiring ongoing management.
    • Current treatments, while effective short-term, are associated with high relapse rates.
    • Further research is crucial to understand the long-term prognosis and optimize management strategies for EE.